Cardan Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$552K Buy
3,421
+105
+3% +$17.9K 0.06% 153
2021
Q2
$546K Sell
3,316
-159
-5% -$26.3K 0.06% 154
2021
Q1
$571K Sell
3,475
-581
-14% -$94K 0.07% 146
2020
Q4
$638K Buy
4,056
+886
+28% +$131K 0.08% 130
2020
Q3
$472K Buy
3,170
+365
+13% +$54K 0.06% 151
2020
Q2
$394K Buy
2,805
+663
+31% +$96.6K 0.06% 158
2020
Q1
$281K Buy
2,142
+742
+53% +$105K 0.05% 152
2019
Q4
$204K Buy
+1,400
New +$190K 0.03% 181
2019
Q2
Sell
-2,223
Closed -$311K 171
2019
Q1
$311K Sell
2,223
-14
-0.6% -$1.88K 0.05% 144
2018
Q4
$289K Hold
2,237
0.05% 142
2018
Q3
$309K Buy
+2,237
New +$297K 0.05% 144
2018
Q2
Sell
-1,590
Closed -$204K 182
2018
Q1
$204K Buy
+1,590
New +$215K 0.03% 176

Other funds holding JNJ

Cardan Capital Partners's JNJ Position: Q3 2021 in Review

Cardan Capital Partners increased its Johnson & Johnson (JNJ) stake by 3.2% in Q3 2021, buying an estimated $17.9K and bringing the position to 3,421 shares worth $552K. The position accounts for 0.06% of the portfolio, ranked #153.

Cardan Capital Partners first reported a position in JNJ in Q1 2018 and has held it in 12 quarters since. The position peaked at $638K in Q4 2020. 3,312 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • Cardan Capital Partners held 3,421 shares of Johnson & Johnson worth $552K as of Q3 2021.
  • Cardan Capital Partners bought 105 Johnson & Johnson shares in Q3 2021, an estimated $17.9K.
  • Johnson & Johnson made up 0.06% of Cardan Capital Partners's portfolio in Q3 2021, its #153 holding.
  • Cardan Capital Partners first reported a position in Johnson & Johnson in Q1 2018 and has held it in 12 quarters since.
  • Cardan Capital Partners's Johnson & Johnson position peaked at $638K in Q4 2020.
  • 3,312 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.